Cargando...
Gamma‐aminobutyric acid agonists for antipsychotic‐induced tardive dyskinesia
BACKGROUND: Chronic antipsychotic drug treatment may cause tardive dyskinesia (TD), a long‐term movement disorder. Gamma‐aminobutyric acid (GABA) agonist drugs, which have intense sedative properties and may exacerbate psychotic symptoms, have been used to treat TD. OBJECTIVES: 1. Primary objective...
Guardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2018
|
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513215/ https://ncbi.nlm.nih.gov/pubmed/29663328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000203.pub4 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|